The global cognitive neuroscience market size was valued at USD 38,920 million in 2024 and is expected to reach USD 74,442 million by 2034, growing at a CAGR of 6.7% from 2024 to 2034.
Cognitive neuroscience is the scientific study of mental processes like consciousness action, memory, perception common decision-making, and selective attention. The main purpose of cognitive neuroscience is to measure the brain activity associated with mental processes. The rising incidences of neurological disorders and mental health issues create awareness about cognitive health and advanced diagnostic tools with better therapeutic outcomes driving the market for cognitive neuroscience. The use of functional magnetic resonance imaging and electroencephalography in clinical practices helps with understanding of brain functions and disorders that expand the market. Also, the demand for personalized medicines creates opportunities for companies to enhance their product offering and expand the market for cognitive neuroscience.
As the population ages the need for cognitive health becomes an important factor to study various disease-related conditions, where advanced diagnostic tools with the development of innovative imaging techniques and software will provide healthcare professionals with accurate assessment of the cognitive functions and gaining deeper insights into the brains working.
Furthermore, the rising investments in the healthcare sector for the development of effective treatments along with the changing lifestyle of the individuals and the increasing number of rod accidents that lead to neurological and cognitive dysfunctions is driving the market for cognitive neuroscience for more precise than accurate treatment options.
Published by Ajit Bansod
